MISSING HLA C GROUP 1 LIGAND IN PATIENTS WITH AML AND MDS IS ASSOCIATED WITH REDUCED RISK OF RELAPSE AND IMPROVED SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH FLUDARABINE AND TREOSULFAN REDUCED TOXICITY CONDITIONING
Abstract
Data di Pubblicazione:
2014
Tipologia CRIS:
1.5 Abstract in rivista
Elenco autori:
Shimoni, A; Bernardi, M; Yerushalmi, R; Peccatori, J; Shem-Tov, N; Lo Russo, A; Volchek, Y; Vago, L; Bonini, C; Stanghellini, Mtl; Nagler, A; Ciceri, F
Link alla scheda completa:
Pubblicato in: